secwatch.observer — SEC 8-K summary
======================================

Issuer:     PRECISION BIOSCIENCES INC (DTIL)
CIK:        0001357874
Form:       8-K
Filed at:   2026-03-17T23:59:59+00:00
Accession:  0001628280-26-018397
Event type: other
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Precision BioSciences hosts KOL event for PBGENE-DMD DMD program; no new data disclosed
--------------------------------------------------------------------------------

- KOL event on March 17, 2026 features Dr. Veerapandiyan and Pat Furlong discussing DMD unmet need and treatment landscape.
- Overview of PBGENE-DMD gene editing program and FUNCTION-DMD Phase 1/2 trial presented; no new clinical or financial data released.
- Presentation materials and webcast replay available on Precision BioSciences investor website.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1357874/000162828026018397/0001628280-26-018397-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1357874/000162828026018397/dtil-20260317.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-018397

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer